CHU Bretonneau

Our multidisciplinary team aims to provide care and support for patients and their families. Patients are routinely (every three months) seen by specialists in our team. Together with the NeuroCenter Network we coordinate medical, paramedical and social support at home for patients. We also take part in various research activities. These are directed to identify ALS risk genes, new biomarkers for diagnosis and prognosis, and clinical studies to develop suitable treatments. Finally, we are setting up an ALS Registry in the Center Val de Loire.

Contact
Location
CHU Bretonneau 2 Boulevard Tonnellé, 37044 Tours

Specialists

Philippe Corcia

Professor of Neurology

Philippe Corcia is Professor of Neurology and responsible for the ALS Center […]

Philippe Corcia
Current trials
In preparation
Phase iii

MAGNET

Platform trial
MAGNET is an innovative clinical platform trial in which multiple treatments for ALS are investigated simultaneously.
Read more
Recruiting
Phase iii

TUDCA-ALS (TUDCA)

Industry trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more